Literature DB >> 2015610

National Cancer Institute roundtable on prostate cancer: future research directions.

A Chiarodo1.   

Abstract

It is anticipated that this report will serve as a nucleus for stimulating meaningful studies of the biology of prostate cancer. Such studies will be essential for the control and ultimately the prevention of prostate cancer. The present focus was arrived at by consensus of an expert panel on prostate cancer. It is not the only focus and other developing areas will surely be opportune for new and creative research approaches. New concepts and novel treatments are urgently required to stem the increasing impact of prostate cancer.

Entities:  

Mesh：

Year:  1991        PMID： 2015610

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


  18 in total

1.  Local staging of prostate carcinoma with endorectal coil MRI: correlation with whole-mount radical prostatectomy specimens.

Authors:  C Bartolozzi; I Menchi; R Lencioni; S Serni; A Lapini; G Barbanti; A Bozza; A Amorosi; A Manganelli; M Carini
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  Similar clinical outcomes in African-American and non-African-American males treated with suramin for metastatic prostate cancer.

Authors:  R C Bergan; R G Walls; W D Figg; N A Dawson; D Headlee; A Tompkins; S M Steinberg; E Reed
Journal:  J Natl Med Assoc       Date:  1997-09       Impact factor: 1.798

Review 3.  The convergence of hormone regulation and cell cycle in prostate physiology and prostate tumorigenesis.

Authors:  Joanne N Davis; Mark L Day
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

4.  Expression and localization of urokinase-type plasminogen activator in human spinal column tumors.

Authors:  Z L Gokaslan; S K Chintala; J E York; V Boyapati; S Jasti; R Sawaya; G Fuller; D M Wildrick; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1998-11       Impact factor: 5.150

Review 5.  Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications.

Authors:  L A Giroldi; J A Schalken
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

6.  A novel approach to the characterization of whole prostate pathology in glycol methacrylate.

Authors:  L E Monger; M Nagabhushan; T G Pretlow; T P Pretlow
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

7.  Androgen receptor gene mutations in human prostate cancer.

Authors:  J R Newmark; D O Hardy; D C Tonb; B S Carter; J I Epstein; W B Isaacs; T R Brown; E R Barrack
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

8.  Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.

Authors:  D Samid; S Shack; C E Myers
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer.

Authors:  Charles J Rosser; Deborah A Kuban; Sang-Joon Lee; Lawrence B Levy; Curtis Pettaway; Ashish M Kamat; Ramsey Chichakli; Andrew Lee; Rex M Cheung; Ricardo Sanchez-Ortiz; Louis L Pisters
Journal:  J Natl Med Assoc       Date:  2004-07       Impact factor: 1.798

10.  Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States).

Authors:  K L Danley; J L Richardson; L Bernstein; B Langholz; R K Ross
Journal:  Cancer Causes Control       Date:  1995-11       Impact factor: 2.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.